Kory Wentworth
Director of Finance/CFO at ENTRADA THERAPEUTICS, INC.
Net worth: 1 M $ as of 30/04/2024
Profile
Kory James Wentworth is currently the Chief Financial Officer & Treasurer at Entrada Therapeutics, Inc. Prior to this, he worked as the Executive Director & Corporate Controller at Alexion Pharmaceuticals, Inc. from 2008 to 2017 and as the Treasurer & Vice President-Finance at bluebird bio, Inc. from 2017 to 2020.
He completed his undergraduate degree at Susquehanna University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ENTRADA THERAPEUTICS INC
0.25% | 15/03/2024 | 83,170 ( 0.25% ) | 1 M $ | 30/04/2024 |
Kory Wentworth active positions
| Companies | Position | Start |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Director of Finance/CFO | 01/11/2020 |
Former positions of Kory Wentworth
| Companies | Position | End |
|---|---|---|
| BLUEBIRD BIO, INC. | Comptroller/Controller/Auditor | 08/09/2020 |
| ALEXION PHARMACEUTICALS, INC. | Director/Board Member | 01/12/2017 |
Training of Kory Wentworth
| Susquehanna University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Kory Wentworth
